These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17804276)

  • 1. Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
    Crouch PJ; Harding SM; White AR; Camakaris J; Bush AI; Masters CL
    Int J Biochem Cell Biol; 2008; 40(2):181-98. PubMed ID: 17804276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of mitochondrial amyloid-beta in Alzheimer's disease.
    Chen JX; Yan SS
    J Alzheimers Dis; 2010; 20 Suppl 2():S569-78. PubMed ID: 20463403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights from Drosophila models of Alzheimer's disease.
    Cowan CM; Shepherd D; Mudher A
    Biochem Soc Trans; 2010 Aug; 38(4):988-92. PubMed ID: 20658990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade.
    Wirths O; Multhaup G; Bayer TA
    J Neurochem; 2004 Nov; 91(3):513-20. PubMed ID: 15485483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular aspects of neurodegeneration in Alzheimer's disease.
    Russo C; Venezia V; Salis S; Dolcini V; Schettini G
    Funct Neurol; 2002; 17(2):65-70. PubMed ID: 12224792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking molecular motors to Alzheimer's disease.
    Stokin GB; Goldstein LS
    J Physiol Paris; 2006; 99(2-3):193-200. PubMed ID: 16459060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal weapon: amyloid beta-peptide, role in the oxidative stress and neurodegeneration of Alzheimer's disease.
    Lahiri DK; Greig NH
    Neurobiol Aging; 2004; 25(5):581-7. PubMed ID: 15172733
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
    Aliyev A; Chen SG; Seyidova D; Smith MA; Perry G; de la Torre J; Aliev G
    J Neurol Sci; 2005 Mar; 229-230():285-92. PubMed ID: 15760652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau.
    Hardy J; Duff K; Hardy KG; Perez-Tur J; Hutton M
    Nat Neurosci; 1998 Sep; 1(5):355-8. PubMed ID: 10196523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide.
    Chen JX; Yan SD
    Expert Rev Neurother; 2007 Nov; 7(11):1517-25. PubMed ID: 17997700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid beta peptides and glutamatergic synaptic dysregulation.
    Parameshwaran K; Dhanasekaran M; Suppiramaniam V
    Exp Neurol; 2008 Mar; 210(1):7-13. PubMed ID: 18053990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol, synaptic function and Alzheimer's disease.
    Koudinov AR; Koudinova NV
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S107-12. PubMed ID: 14574623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression?
    Small DH
    Trends Mol Med; 2008 Mar; 14(3):103-8. PubMed ID: 18262842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial biology in Alzheimer's disease pathogenesis.
    Galindo MF; Ikuta I; Zhu X; Casadesus G; Jordán J
    J Neurochem; 2010 Aug; 114(4):933-45. PubMed ID: 20492350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease.
    Veurink G; Fuller SJ; Atwood CS; Martins RN
    Ann Hum Biol; 2003; 30(6):639-67. PubMed ID: 14675907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease.
    Cardoso SM; Pereira CF; Moreira PI; Arduino DM; Esteves AR; Oliveira CR
    Exp Neurol; 2010 Jun; 223(2):294-8. PubMed ID: 19559703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
    Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G
    Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein.
    Kawahara M; Negishi-Kato M; Sadakane Y
    Expert Rev Neurother; 2009 May; 9(5):681-93. PubMed ID: 19402778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The essential role of lipids in Alzheimer's disease.
    Florent-Béchard S; Desbène C; Garcia P; Allouche A; Youssef I; Escanyé MC; Koziel V; Hanse M; Malaplate-Armand C; Stenger C; Kriem B; Yen-Potin FT; Olivier JL; Pillot T; Oster T
    Biochimie; 2009 Jun; 91(6):804-9. PubMed ID: 19303044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper imbalance and oxidative stress in neurodegeneration.
    Rossi L; Arciello M; Capo C; Rotilio G
    Ital J Biochem; 2006; 55(3-4):212-21. PubMed ID: 17274527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.